Works matching IS 00207136 AND DT 2016 AND VI 139 AND IP 1


Results: 29
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Issue Information - UICC.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 1, p. 7, doi. 10.1002/ijc.29765
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    17
    18
    19
    20

    Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 1, p. 85, doi. 10.1002/ijc.29911
    By:
    • Halec, Gordana;
    • Schmitt, Markus;
    • Egger, Sam;
    • Abnet, Christian C.;
    • Babb, Chantal;
    • Dawsey, Sanford M.;
    • Flechtenmacher, Christa;
    • Gheit, Tarik;
    • Hale, Martin;
    • Holzinger, Dana;
    • Malekzadeh, Reza;
    • Taylor, Philip R.;
    • Tommasino, Massimo;
    • Urban, Margaret I.;
    • Waterboer, Tim;
    • Pawlita, Michael;
    • Sitas, Freddy
    Publication type:
    Article
    21
    22
    23

    TERT promoter mutations in melanoma survival.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 1, p. 75, doi. 10.1002/ijc.30042
    By:
    • Nagore, Eduardo;
    • Heidenreich, Barbara;
    • Rachakonda, Sívaramakrishna;
    • Garcia‐Casado, Zaida;
    • Requena, Celia;
    • Soriano, Virtudes;
    • Frank, Christoph;
    • Traves, Victor;
    • Quecedo, Esther;
    • Sanjuan‐Gimenez, Josefa;
    • Hemminki, Kari;
    • Landi, Maria Teresa;
    • Kumar, Rajiv
    Publication type:
    Article
    24
    25

    Erratum.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 1, p. E1, doi. 10.1002/ijc.30058
    Publication type:
    Article
    26
    27
    28
    29

    A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 1, p. 177, doi. 10.1002/ijc.30049
    By:
    • Eng, Cathy;
    • Bessudo, Alberto;
    • Hart, Lowell L.;
    • Severtsev, Aleksey;
    • Gladkov, Oleg;
    • Müller, Lothar;
    • Kopp, Mikhail V.;
    • Vladimirov, Vladimir;
    • Langdon, Robert;
    • Kotiv, Bogdan;
    • Barni, Sandro;
    • Hsu, Ching;
    • Bolotin, Ellen;
    • von Roemeling, Reinhard;
    • Schwartz, Brian;
    • Bendell, Johanna C.
    Publication type:
    Article